Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

240
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
240
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

324
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
324
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

207
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
207
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

611
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
611
Depressants01:28

Depressants

165
Depressant drugs, including alcohol and sedative-hypnotics, diminish central nervous system activity by enhancing the action of gamma-aminobutyric acid (GABA), a neurotransmitter that reduces brain activity and promotes relaxation. These substances can have various therapeutic uses but also pose significant risks, especially when misused or combined.
Alcohol is a common depressant that can induce a sense of relaxation and reduced inhibition at low doses. Contrary to its occasional...
165
Aging01:26

Aging

139
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
139

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Misuse of opioid analgesics in elderly patients: a review.

Geriatrie et psychologie neuropsychiatrie du vieillissement·2021
Same author

[Substance use disorders and addictions among carers].

Soins; la revue de reference infirmiere·2020
Same author

[Analgesic opioids misuse in the elderly: A review].

Geriatrie et psychologie neuropsychiatrie du vieillissement·2020
Same author

[Day hospitalisation in addictology].

Soins. Psychiatrie·2019
Same author

[Medicines and elderly patients: abuse, dependency or attraction?]

Soins. Gerontologie·2017
Same author

[Alcohol intoxication in old age].

Soins. Gerontologie·2017

Related Experiment Video

Updated: Aug 17, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

982

[Identifying and treating alcohol use disorders in the elderly].

Pascal Menecier1, Perrine Broyer2

  • 1Praticien hospitalier, service d'addictologie, CH Les Chanaux, Mâcon, France ; docteur en psychologie, institut de psychologie, université Lumière- Lyon-2, Bron, France, équipe de recherche DIPHE.

La Revue Du Praticien
|December 13, 2022
PubMed
Summary

Alcohol use disorders are common in older adults and pose significant health risks, often going undiagnosed. Early screening and adapted treatment strategies lead to positive outcomes for elderly patients.

Keywords:
AgedAlcoholism

More Related Videos

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
07:31

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

8.1K
A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
08:05

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers

Published on: January 5, 2018

9.8K

Related Experiment Videos

Last Updated: Aug 17, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

982
Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
07:31

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

8.1K
A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
08:05

A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers

Published on: January 5, 2018

9.8K

Area of Science:

  • Gerontology
  • Addiction Medicine
  • Public Health

Context:

  • Alcohol use disorders (AUDs) persist in older populations, with age exacerbating risks.
  • Comorbidities and polypharmacy in the elderly amplify alcohol-related harm.
  • AUDs in older adults are frequently undiagnosed until complications arise.

Purpose:

  • To highlight the prevalence and risks of alcohol use disorders in the elderly.
  • To emphasize the need for systematic screening and adapted care strategies.
  • To underscore the positive prognosis for treating AUDs in older individuals.

Summary:

  • Aging does not eliminate alcohol use disorders; it increases susceptibility to alcohol's adverse effects.
  • Polypathology and polypharmacy in the elderly heighten risks associated with alcohol consumption.
  • Undiagnosed AUDs in older adults often present with severe complications, necessitating proactive identification.

Impact:

  • Systematic screening is crucial for early detection of AUDs in the elderly.
  • Adapted treatment approaches offer a good to excellent prognosis for older individuals with AUDs.
  • Recognizing and addressing AUDs in aging populations improves health outcomes and reduces healthcare burdens.